Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 21 citing articles:

Single-cell RNA sequencing and immune microenvironment analysis reveal PLOD2-driven malignant transformation in cervical cancer
Zhiheng Lin, Fengxin Wang, Renwu Yin, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 3
MAZ-mediated tumor progression and immune evasion in hormone receptor-positive breast cancer: Targeting tumor microenvironment and PCLAF+ subtype-specific therapy
Gaofeng Ni, Yuwei Sun, Hongling Jia, et al.
Translational Oncology (2025) Vol. 52, pp. 102280-102280
Closed Access | Times Cited: 3
Characterizing tumor biology and immune microenvironment in high-grade serous ovarian cancer via single-cell RNA sequencing: insights for targeted and personalized immunotherapy strategies
Fu Zhao, Xiaojing Jiang, Yumeng Li, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Progress in immune microenvironment, immunotherapy and prognostic biomarkers in pediatric osteosarcoma
Lin Zhang, Haoming Jiang, Hongzhi Ma
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma
Rachel G. Liao, Jinhong Wang, Fan Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Inhibition of programmed cell death by melanoma cell subpopulations reveals mechanisms of melanoma metastasis and potential therapeutic targets
Yuepeng An, Fu Zhao, Hongling Jia, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
The association between body composition and overall survival in patients with advanced non-small cell lung cancer
Liang Fu, Haiming Ding, Li Dong Mo, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Single-cell RNA sequencing revealed PPARG promoted osteosarcoma progression: based on osteoclast proliferation
Lei Sun, Jinhao Zhang, Zhikai Xiahou, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Sesquiterpene lactones and cancer: new insight into antitumor and anti-inflammatory effects of parthenolide-derived Dimethylaminomicheliolide and Micheliolide
Jian Li, Xin Li, Hongwei Liu
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Discovering the Potential Role of the C2 DUSP2+ MCs Subgroup in Lung Adenocarcinoma
Shengyi Zhang, Xinhan Li, Zhikai Xiahou, et al.
Translational Oncology (2025) Vol. 54, pp. 102295-102295
Closed Access
BUB1B promotes cisplatin resistance in gastric cancer via Rad51-mediated DNA damage repair
Zhe Qin, Fangzhou Ye, Jiayi Wang, et al.
Translational Oncology (2025) Vol. 54, pp. 102334-102334
Closed Access
Exposing the cellular situation: findings from single cell RNA sequencing in breast cancer
Gaofeng Ni, Xinhan Li, Wenyang Nie, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Single-cell insights into HNSCC tumor heterogeneity and programmed cell death pathways
Yuanhao Chai, Jianlin Zhang, Wenwen Shao, et al.
Translational Oncology (2025) Vol. 54, pp. 102341-102341
Closed Access
The Potential Role of C4 MYH11+ Fibroblasts and the MDK-SDC2 Ligand-Receptor Pair in Lung Adenocarcinoma: Implications for Prognosis and Therapeutic Strategies
H. Jia, Yanjie Bian, Jie Yuan, et al.
Translational Oncology (2025) Vol. 55, pp. 102364-102364
Closed Access
Investigation of the role of GEM in systemic lupus erythematosus through multi-omics joint analysis
Ruofei Chen, Xiao Zhang, Yifang Shang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Single-cell RNA sequencing in diffuse large B-cell lymphoma: tumor heterogeneity, microenvironment, resistance, and prognostic markers
Linwei Li, Qiwei Li, Rui Niu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Heterogeneity of cancer-associated fibroblast subpopulations in prostate cancer: Implications for prognosis and immunotherapy
Chen Ding, Jian‐Ge Wang, Jie Wang, et al.
Translational Oncology (2024) Vol. 52, pp. 102255-102255
Closed Access | Times Cited: 4
Identification of a novel immune checkpoint-related gene signature predicts prognosis and immunotherapy in breast cancer and experiment verification
Yin Ke, Y. Guo, Jinqiu Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Multi-omics analyses were combined to construct ubiquitination-related features in colon adenocarcinoma and identify ASNS as a novel biomarker
Zhaohui Wang, Wenbing Zhang, Xin Yin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Single-cell RNA sequencing reveals key molecular drivers and immune landscape in uveal melanoma: implications for targeted therapy and prognostic modeling
Zeyu Song, Wenwen Shao, Zhikai Xiahou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
A new perspective on macrophage-targeted drug research: the potential of KDELR2 in bladder cancer immunotherapy
Zhiyi Zhao, Hongling Jia, Zhou Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Innovative strategies to optimise colorectal cancer immunotherapy through molecular mechanism insights
Quanjun Lin, Zhiqiang Wang, Jue Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Single-cell analysis identified key macrophage subpopulations associated with atherosclerosis
Zhenzhen Zhao, Yuelong Qin, Rui Wu, et al.
Open Medicine (2024) Vol. 19, Iss. 1
Open Access
Page 1

Scroll to top